Skip to main content
Caplight Logo









Gênica Inovação Biotecnológica

Gênica Inovação Biotecnológica

Private
PiracicabaFrontier & Industrial Techhttps://genica.com.br/site/

Last Round

Series C

Jun 26, 2024

Est. Valuation

$100M

Total Funding Raised

$16.24M

Company Overview

Gênica Inovação Biotecnológica is a biotechnology company that develops and provides bio-inputs and regenerative solutions for the agricultural sector.

Sector

Frontier & Industrial Tech

Verticals

Biotechnology, Sustainable Materials

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

bio-inputsag biologicalsagricultural biotechnologybiopesticidesagtechinoculantsbiostimulantssustainable agriculturebiological crop protectionregenerative agriculturesoil nutritionagricultural inputs

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Gênica Inovação Biotecnológica Comparables

Compare Gênica Inovação Biotecnológica with similar companies based on industry and business-model similarity.

Gênica Inovação Biotecnológica comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Agrivalle Brasil
88%
Simbiose Agro
87%
Ballagro Agro Tecnologia
86%

Gênica Inovação Biotecnológica Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CJun 26, 2024
Series BMay 10, 2022
SeedJan 1, 2017

Key People

Founding team and executive leadership

Marcos Petean

CEO

Executive Team

Frederico Biasioli

Chief Financial Officer

Executive Team

Gênica Inovação Biotecnológica Investors

Notable investors and investment history

Gênica Inovação Biotecnológica investors
InvestorRounds
SP VenturesSeries B, Series C, Seed
Vox CapitalSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 26, 2024

    $12M round led by Mitsubishi Corporation (Americas)

  • Nov 16, 2023

    Grew 24% QoQ, from 149 to 185 employees.

Gênica Inovação Biotecnológica Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Gênica Inovação Biotecnológica Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Gênica Inovação Biotecnológica's valuation, stock price, and market status.

Firmographic Details

HeadquartersPiracicaba
Employee Range258
Year Founded2015
Last FundingJun 26, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?